Summary
This 8-K/A filing from CHURCH & DWIGHT CO INC /DE/ (CHD) is an amendment to a previous filing, providing crucial financial details regarding the acquisition of the Oral Care Business from Unilever. The report includes audited and unaudited financial statements of the acquired business, as well as pro forma financial information reflecting the impact of the acquisition on Church & Dwight's overall financial position. This information is essential for investors to understand the financial performance of the acquired assets and their potential contribution to the company's future results. The filing details the net assets sold, revenues, and expenses of the Unilever Oral Care Business, including brands like Mentadent, Close-Up, Aim, and Pepsodent. It also outlines the pro forma impact of the acquisition on Church & Dwight's consolidated statements of income and balance sheet, assuming the acquisition occurred at the beginning of the reporting periods. Investors should pay close attention to the purchase price allocation, the resulting goodwill and intangible assets, and the incremental interest expense associated with financing the transaction.
Key Highlights
- 1Amendment to a previous 8-K filing to provide detailed financial information for the acquired Unilever Oral Care Business.
- 2Includes audited financial statements for the Oral Care Business for the year ended December 31, 2002, and unaudited interim statements for the nine months ended September 27, 2003.
- 3The acquired business includes brands such as Mentadent, Close-Up, Aim, and Pepsodent.
- 4Pro forma financial data is presented for the year ended December 31, 2002, and the nine months ended September 27, 2003, reflecting the acquisition's impact.
- 5The total purchase price for the Oral Care Business was approximately $110.6 million, funded through existing cash and new term loans.
- 6The acquisition resulted in the creation of approximately $48.5 million in goodwill and $32.4 million in tradename intangibles.
- 7A Transitional Services Agreement is in place with Unilever, extending services until January 16, 2004.